Sulfonylurea Use During Entire Pregnancy in Diabetes Because of KCNJ11 Mutation: A Report of Two Cases

被引:15
作者
Gaal, Zsolt [3 ]
Klupa, Tomasz [1 ,2 ]
Kantor, Irene [4 ]
Mlynarski, Wojciech [5 ]
Albert, Laszlo [6 ]
Tolloczko, Justyna [7 ]
Balogh, Istvan [8 ]
Czajkowski, Krzysztof [9 ]
Malecki, Maciej T. [1 ,2 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Malopolskie, Poland
[2] Univ Hosp, Krakow, Malopolskie, Poland
[3] Josa Andras Teaching Hosp, Dept Med 4, Nyiregyhaza, Szabolcs Szatma, Hungary
[4] Josa Andras Teaching Hosp, Dept Pediat, Nyiregyhaza, Szabolcs Szatma, Hungary
[5] Med Univ Lodz, Dept Pediat, Lodz, Lodzkie, Poland
[6] Josa Andras Teaching Hosp, Dept Obstet & Gynecol, Nyiregyhaza, Szabolcs Szatma, Hungary
[7] Warsaw Med Univ, Dept Neonatol & Neonatal Intens Care, Warsaw, Mazowieckie, Poland
[8] Univ Debrecen, Dept Lab Med, H-4012 Debrecen, Hajdu Bihar, Hungary
[9] Warsaw Med Univ, Dept Obstet & Gynecol 2, Warsaw, Mazowieckie, Poland
关键词
ACTIVATING MUTATIONS; KIR6.2;
D O I
10.2337/dc12-0163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E40 / E40
页数:1
相关论文
共 5 条
[1]   Relapsing diabetes can result from moderately activating mutations in KCNJ11 [J].
Gloyn, AL ;
Reimann, F ;
Proks, P ;
Pearson, ER ;
Temple, IK ;
Mackay, DJG ;
Shield, JPH ;
Freedenberg, D ;
Noyes, K ;
Ellard, S ;
Ashcroft, FM ;
Gribble, FM ;
Hattersley, AT .
HUMAN MOLECULAR GENETICS, 2005, 14 (07) :925-934
[2]   Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes [J].
Gloyn, AL ;
Pearson, ER ;
Antcliff, JF ;
Proks, P ;
Bruining, GJ ;
Slingerland, AS ;
Howard, N ;
Srinivasan, S ;
Silva, JMCL ;
Molnes, J ;
Edghill, EL ;
Frayling, TM ;
Temple, IK ;
Mackay, D ;
Shield, JPH ;
Sumnik, Z ;
van Rhijn, A ;
Wales, JKH ;
Clark, P ;
Gorman, S ;
Aisenberg, J ;
Ellard, S ;
Njolstad, PR ;
Ashcroft, FM ;
Hattersley, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1838-1849
[3]   The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes:: evidence for heterogeneity of beta cell function among carriers of the R201H mutation [J].
Klupa, T ;
Edghill, E ;
Nazim, J ;
Sieradzki, J ;
Ellard, S ;
Hattersley, A ;
Malecki, M .
DIABETOLOGIA, 2005, 48 (05) :1029-1031
[4]   Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea [J].
Klupa, T. ;
Skupien, J. ;
Mirkiewicz-Sieradzka, B. ;
Gach, A. ;
Noczynska, A. ;
Szalecki, M. ;
Kozek, E. ;
Sieradzki, J. ;
Mlynarski, W. ;
Malecki, M. T. .
DIABETIC MEDICINE, 2009, 26 (06) :664-664
[5]   Clinical Case Seminar The First Case Report of Sulfonylurea Use in a Woman with Permanent Neonatal Diabetes Mellitus due to KCNJ11 Mutation during a High-Risk Pregnancy [J].
Klupa, Tomasz ;
Kozek, Elzbieta ;
Nowak, Natalia ;
Cyganek, Katarzyna ;
Gach, Agnieszka ;
Milewicz, Tomasz ;
Czajkowski, Krzysztof ;
Tolloczko, Justyna ;
Mlynarski, Wojciech ;
Malecki, Maciej T. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08) :3599-3604